Re: Close competitor…
|
1
|
Resverlogix Corp.
|
Oct 21, 2021 05:53PM
|
Re: Closing on the Saudi deal..
|
2
|
Resverlogix Corp.
|
Jan 15, 2021 08:22PM
|
Re: CNBC at the JPM Bio Tech Conference
|
1
|
Resverlogix Corp.
|
Jan 07, 2019 10:10AM
|
Re: CNBC at the JPM Bio Tech Conference
|
3
|
Resverlogix Corp.
|
Jan 07, 2019 10:34AM
|
Re: CNBC at the JPM Bio Tech Conference
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 02:50PM
|
Re: COLCORONA trial: Colchicine reduces the risk of COVID-19-related complications
|
1
|
Resverlogix Corp.
|
Jan 24, 2021 08:04AM
|
Re: Collaborating with the Supreme Council of the Arab-African Economy
|
2
|
Resverlogix Corp.
|
Nov 06, 2021 09:41AM
|
Re: Collaborating with the Supreme Council of the Arab-African Economy
|
|
Resverlogix Corp.
|
Nov 03, 2021 09:33AM
|
Re: Collaborating with the Supreme Council of the Arab-African Economy
|
4
|
Resverlogix Corp.
|
Nov 03, 2021 03:57PM
|
Re: Combined effects of BTI & RVX
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 06, 2021 11:42AM
|
Re: Combined effects of BTI & RVX
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 07, 2021 10:38AM
|
Re: Come on RVX ... ONE TIME
|
5
|
Resverlogix Corp.
|
Oct 09, 2019 10:36AM
|
Re: Comments on the AGM
|
5
|
Resverlogix Corp.
|
Nov 08, 2019 11:30AM
|
Re: Comments on today's annual update
|
2
|
Resverlogix Corp.
|
Jun 23, 2021 05:26AM
|
Re: Comments on today's annual update
|
5
|
Resverlogix Corp.
|
Jun 23, 2021 06:34AM
|
Re: Compensation Commity
|
3
|
Resverlogix Corp.
|
Mar 28, 2021 02:17PM
|
Re: Competition
|
3
|
Resverlogix Corp.
|
Nov 28, 2021 01:56PM
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
3
|
Resverlogix Corp.
|
Jun 02, 2022 02:21PM
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
1
|
Resverlogix Corp.
|
May 26, 2022 07:26AM
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
2
|
Resverlogix Corp.
|
May 26, 2022 09:21AM
|